Answers are grounded in this paper and cite their sources.
Rare bleeding disorders result in significant morbidity but are globally underdiagnosed. Advances in genomic testing and specialist laboratory assays have greatly increased the diagnostic armamentarium. This has resulted in the discovery of new genetic causes for rare diseases and a better understanding of the underlying molecular pathology.
No takes yet. Share an insight, caveat, or question.
Meijer et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: